Aurum Healthcare

Aurum Healthcare is an ISO: 13485 Certified Company focused to provide innovative solutions to reduce the spread of infection and to advance medical device technologies. Aurum Healthcare offers a range of medical devices for cardiacvascular, cardiology, orthopaedics, anaesthesiology and critical care monitoring kits.

Aurum Healthcare serves the hospitals, clinical laboratories and
distributors in the medical device industry. The company is constantly engaging
the industry and healthcare professionals to improve its medical devices,
ensuring that the customers continue to have access to safe, cost-effective and
high quality medical devices.

Aurum Healthcare stands for GOLD  standard in healthcare. In
the Iskandar Malaysia in Southern Johor, Aurum Healthcare commenced its
operations in 2011 led by a team of professionals with extensive years of
medical device experience. Aurum Healthcare is a leading R&D company that
has made significant investments into high technology projects building
specialty medical devices with the potential to address serious diseases for which
the unmet medical needs is high and the biology treatment is clear.

We have carried out a series of training to equip our staff with
the capabilities and the competencies in the R&D of the medical devices.
These include training our staff in the application of new medical technologies
and understanding the regulatory framework of FDA and the CE Mark compliance.
Local staff is also trained in the application of the latest medical
sterilization processes and the Quality Management System ISO 13485.

Aurum Healthcare has invested in building a state-of-art
ethylene oxide (EO) medical sterilization facility. We provide contract
sterilization to companies and is committed to delivering high quality and
customer-focused sterilization services.

Aurum Healthcare is also embarking on a new medical technology
to develop a novel specially coated technology known as Aurum HydroPlus onto
existing medical devices such as cardiopulmonary tubing and central venous
catheters. This breakthrough technology can effectively prevent blood clotting,
suppression of proteins and cells to reduce the incidences of infection during
and after the surgical intervention. Aurum HydroPlus specially
coated medical devices are designed with the ability to go more places, help
facilitate ease of insertion and promote optimal protection and performance. We
have specifically designed the devices to protect patients during the
interventional cardiac surgery by minimizing trauma and by enabling less
invasive surgical techniques.

Aurum Healthcare seeks to capitalize on a unique opportunity
that exists in the medical device industry by deploying our extensive
experience in the medical device industry. "We work closely with industry
partners, doctors and the research institutes to develop cutting edge
technologies and accelerating the commercialisation outcomes of these new
devices", says Patrick Chua, COO of Aurum Healthcare.

Malaysia is uniquely positioned as a regional hub for business,
innovation and talent. Our decision to invest in Malaysia is supported by a
primary value proposition that is centred on costs, capabilities, intellectual
property protection and infrastructure. The Iskandar region in Johor has all
the right ingredients to be a destination of choice for us to set up our operations,
says Chua.

Malaysia is a country of choice for Aurum Healthcare as the
healthcare industry has been identified as a National Key Economic Area that
is complemented by the several factors such as a stable and attractive business
environment, pro-business policies and incentives, productive workforce with
English widely-spoken amongst the people.

Malaysia is also strategically located to allow Aurum Healthcare
to optimize the supply chain management to serve the fast-growing Asian market.
Aurum Healthcare's current expansion of its business for its new range of Aurum
HydroPlus specially coated medical devices for cardiopulmonary kits and the central venous
catheters will involve further investment of RM35 million. This investment will
result in the commercialization of novel medical devices and the development of
new medical technologies.

We believe in working closely on an ecosystem of partnerships
for success, united by a collaborative model to deliver better results that are
vital to the patients. We view MIDA as our growth partner. The workforce in
Malaysia is young, educated and highly productive at costs that are very
competitive with the neighbouring countries in Asia. We will recruit and
develop more qualified local staff to run more complex processes and
machines", says Chua.

Aurum Healthcare will draw upon the support from MIDA to enhance
its core competencies and capabilities in the development of the new specialty
medical devices. Besides the R&D, Aurum Healthcare will also build up its
capabilities in the commercial assessment, product development, manufacturing,
clinical trials, regulatory clearance, and go-to-market strategies. Whatever
medical devices that Aurum Healthcare does offer, we will make great efforts to
ensure that they are of the highest quality and are in line with the demands of
the market.

In January 2014, Aurum Healthcare has secured one of its early
successes, having sealed a strategic partnership with Medtronic International,
the world's largest medical device company to market the Aurum HydroPlus specially
coated medical devices for cardiopulmonary kits once they are ready for
commercialization.